The end of an era as these 3 colleagues finish their tenure in the lab. Each the product of supportive programs to help them launch their journey and now off to med school, postdoc and grad school. Will miss you all but super excited for your future. Jakayla, Bobbie, Alexa - Go get em.

First time we’ve had the honor of the @dallasmorningnews.bsky.social writing about our scientific discoveries, funded by the #NIH www.dallasnews.com/news/2025/05...

Excited to introduce Dr. Bobbie Brown, who happens to be our lab’s PhD #15. With co-mentor Bryan Copits.

Send good vibes to our colleagues at NIH folks.

BOOM! Human DRG patch-seq with Nav1.8 and Nav1.7 upregulation associated with a history pain in organ donors. www.biorxiv.org/content/10.1... Great stuff from the #PRECISIONPain Center at WashU led by @robgereau.bsky.social

Science is under threat in the US. @elife.bsky.social have commissioned a series of articles discussing the implications and what we can do. The first three articles are now live. More to follow: elifesciences.org/articles/106... elifesciences.org/articles/106... elifesciences.org/articles/106...

New work from the lab published at @cp-neuron.bsky.social. In this study we dissect the role of hormonal regulation in pain-induced enhanced opioid intake in males. Work conducted by the super talented @jessinbotham www.cell.com/neuron/fullt...

Opioids remain a common treatment for chronic pain — but at a cost. Now, scientists at WashU Medicine and Stanford University have developed a pain-relieving compound that mimics cannabis' benefits without the mind-altering side effects or risk of addiction. medicine.washu.edu/news/compoun...

Excited to present the result of a fantastic collaborative effort - funded by the National Institutes of Health, including the NIH HEAL Initiative, to develop safer analgesic drugs. www.nature.com/articles/s41...

a bit of good news - thak you @jeremymberg.bsky.social for all of the information and insights!

NIH indirects case update: Hearing ongoing now, and I'll try to live tweet some notable exchanges. Prior to more detailed arguments, Judge Kelley starts off with a few point questions to both sides: (I'm paraphrasing here)

Check out the scientific journey behind the newest FDA-approved pain medication! 💊 Learn how NIH-funded research played a crucial role—both directly and indirectly—in bringing this breakthrough to life. 🧪

Threats to science abound. It's been hard for everyone - but the energy in the lab today is incredible. Scientists brainstorming projects, pouring over exciting new data, companies vying to acquire licensing rights to patents we have for potential new #chronicpain treatments. So inspired by our team

🚨 SAVE THE DATE! 🚨 2nd edition of the St. Louis Translational Pain Research Forum! a joint effort between SLU, WashU and UHSP 🗓 Sept 26-27, 2025 🎤 Keynote: Dr. Cheryl Stucky 💡 Plenary: Dr. Patrick Dougherty Register now ->🔗 stl-tprf2023.my.canva.site/stl-tprf2025 #PainResearch #Neuroskyience

A big day for pain care, and for pain science. www.fda.gov/news-events/...

science-ing is amazing these days. www.nature.com/articles/s41...

I just reached out to my senators about the NIH situation. If you need to find out how much impact NIH has in your state in terms of dollars in and their economic impact here's a link: www.unitedformedicalresearch.org/nih-in-your-...

Fantastic work here. A real boost to the KCC2 modulator concept, providing very encouraging validation in human subjects. Ted, Yves, Mike and teams!

If you could only read one article about chronic pain read this #painresearch www.nytimes.com/2025/01/12/m...

There's our very own @julietmwirigi.bsky.social from @washumedicine.bsky.social and the WashU Pain Center.